BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22751111)

  • 1. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.
    Pérez-Gómez E; Andradas C; Flores JM; Quintanilla M; Paramio JM; Guzmán M; Sánchez C
    Oncogene; 2013 May; 32(20):2534-42. PubMed ID: 22751111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.
    Andradas C; Caffarel MM; Pérez-Gómez E; Salazar M; Lorente M; Velasco G; Guzmán M; Sánchez C
    Oncogene; 2011 Jan; 30(2):245-52. PubMed ID: 20818416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
    Sung YM; He G; Hwang DH; Fischer SM
    Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
    Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P
    Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
    Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
    Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Hu G; Ren G; Shi Y
    Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
    Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
    Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis.
    Passeri D; Doldo E; Tarquini C; Costanza G; Mazzaglia D; Agostinelli S; Campione E; Di Stefani A; Giunta A; Bianchi L; Orlandi A
    J Invest Dermatol; 2016 Jun; 136(6):1255-1266. PubMed ID: 26945879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.
    Nibbs RJ; Gilchrist DS; King V; Ferra A; Forrow S; Hunter KD; Graham GJ
    J Clin Invest; 2007 Jul; 117(7):1884-92. PubMed ID: 17607362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.